Touching the heart of HIV-1 drug resistance: The fingers close down on the dNTP at the polymerase active site

Chemistry and Biology

Volumn 6, Issue 5, 1999, Pages

  Sarafianos, Stefan G ^a   Kalyan, Das ^a   Ding, Jianping ^a   Boyer, Paul L ^b   Hughes, Stephen H ^b   Arnold, Edward ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033133780     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80071-4     Document Type: Article

References (68)

1. 1. Esnouf, R., Ren, J., Ross, R., Jones, Y., Stammers, D. & Stuart, D. (1995). Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat. Struct. Biol. 2, 303-308.
2. 2. Rodgers, D.W., et al., & Harrison, S.C. (1995). The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 92, 1222-1226.
3. 3. Hsiou, Y., Ding, J., Das, K., Clark, A.D., Jr., Hughes, S.H. & Arnold, E. (1996). Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure 4, 853-860.
4. 4. Jacobo-Molina, A., et al., & Arnold, E. (1993). Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl Acad. Sci. USA 90, 6320-6324.
5. 5. Ding, J., et al., & Arnold, E. (1997). A review of HIV-1 RT structural studies and implications for drug design. In Structure Based Drug Design. (P. Veerapandian, ed), pp. 41 -82, Marcel Dekker, Inc., New York.
6. 6. Sawaya, M.R., Prasad, R., Wilson, S., Kraut, J. & Pelletier, H. (1997). Crystal structures of human DNA polymerase β complexed with gapped and nicked DNA: evidence for induced fit mechanism. Biochemistry 36, 11205-11215.
7. 7. Pelletier, H., Sawaya, M.R., Kumar, A., Wilson, S.H. & Kraut, J. (1994). Structures of ternary complexes of rat DNA polymerase β, a DNA template-primer, and ddCTP. Science 264, 1891-1903.
8. 8. Doublie, S., Tabor, S., Long, A.M., Richardson, C.C. & Ellenberger, T. (1998). Crystal structure of a bacteriophage T7 DNA replication complex at 2.2 Å resolution. Nature 391, 251-258.
9. 9. Li, Y., Korolev, S. & Waksman, G. (1998). Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase: structural basis for nucleotide incorporation. EMBO J. 17, 7514-7525.
10. 10. Huang, H., Chopra, R., Verdine, G.L. & Harrison, S.C. (1998). Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669-1675.
11. 11. Bebenek, K., et al., & Kunkel, T.A. (1997). A minor groove binding track in reverse transcriptase. Nat. Struct. Biol. 4, 194-197.
12. 12. Ding, J., et al., & Arnold, E. (1998). Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with double-stranded DNA and an antibody Fab fragment at 2.8 Å resolution. J. Mol. Biol. 284, 1095-1111.
13. 13. Eom, S.H., Wang, J. & Steitz, T.A. (1996). Structure of Taq polymerase with DNA at the polymerase active site. Nature 382, 278-281.
14. 14. Pelletier, H., Sawaya, M.R., Wolfle, W., Wilson, S.H. & Kraut, J. (1996). Crystal structures of human DNA polymerase β complexed with DNA: implications for catalytic mechanism, processivity and fidelity. Biochemistry 35, 12742-12761.
15. 15. Ding, J., Hughes, S.H. & Arnold, E. (1997). Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA template-primer. Biopolymers 44, 125-138.
16. 16. Kiefer, J.R., Mao, C., Braman, J.C. & Beese, L.S. (1998). Visualizing DNA replication in a catalytically active Bacillus DNA polymerase crystal. Nature 391, 304-307.
17. 17. Boyer, P.L., et al., & Hughes, S.H. (1994). The sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc. Natl Acad. Sci. USA 91, 4882-4886.
18. 18. Beese, L.S., Derbyshire, V. & Steitz, T.A. (1993). Structure of DNA polymerase I Klenow fragment bound to duplex DNA. Science 260, 352-355.
19. 19. Sarafianos, S.G., Pandey, V.N., Kaushik, N. & Modak, M.J. (1995). Site-directed mutagenesis of Arg72 of HIV-1 reverse transcriptase. J. Biol. Chem. 270, 19279-19735.
20. 20. Harris, D., Kaushik, N., Pandey, P.K., Yadav, P.N.S. & Pandey, V.N. (1998). Functional analysis of amino acid residues constituting the dNTP binding pocket of HIV-1 reverse transcriptase. J. Biol. Chem. 273, 33624-33634.
21. 21. Kaushik, N., Pandey, V.N. & Modak, M.J. (1996). Significance of O helix residues of E, coli pol I in DNA synthesis: Dynamics of dNTP binding pocket. Biochemistry 35, 7256-7266.
22. 22. Beese, L.S. & Steitz, T.A. (1991 ). Structural basis for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I: a two-metal-ion mechanism. EMBO J. 10, 25-33.
23. 23. Huang, S.L. & Tsai, M.D. (1982). Does the Mg (II) ion interact with the alpha phosphate of adenosine triphosphate? An investigation by oxygen-17 nuclear magnetic resonance. Biochemistry 21, 951 -959.
24. 31P NMR of Mg-ATP in dilute solutions, complexation and exchange. Int. J. Biochem. 24, 1533-1559.
25. 25. Joyce, C.M. & Steitz, T.A. (1994). Function and structure relationships in DNA polymerases. Ann. Rev. Biochem. 63, 777-822.
26. 26. Patel, P.H., et al., & Arnold, E. (1995). Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry 34, 5351-5363.
27. 27. Larder, B.A., Purifoy, D.J.M., Powell, K.L. & Darby, G. (1987). Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature 327, 716-717.
28. 28. Boyer, P.L., Ferris, A.L. & Hughes, S.H. (1992). Mutational analysis of the fingers domain of human immunodeficiency virus type-1 reverse transcriptase. J. Virol. 66, 7533-7537.
29. 29. Kaushik, N., Rege, N., Yadav, P.N., Sarafianos, S.G. & Modak, M.J. (1996). Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. Biochemistry 35, 11536-11546.
30. 30. Tabor, S. & Richardson, C.C. (1995). A single residue in DNA polymerases of the Escherichia coli DNA polymerase I family is critical for distinguishing between deoxy-and dideoxyribonucleotides. Proc. Natl Acad. Sci. USA 92, 6339-6343.
31. 31. Tesmer, J.G., Sunahara, R.K., Gilman, A.G. & Sprang, S.R. (1997). Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsα-GTPySγ. Science 278, 1907-1916.
32. 32. Tesmer, J.G., & Sprang, S.R. (1998). The structure, catalytic mechanism and regulation of adenylyl cyclase. Curr. Opin. Struct. Biol. 8, 713-719.
33. 33. Shirasaka, T., et al., & Mitsuya, H. (1995). Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92, 2398-2402.
34. 34. Iversen, A.K.N., et al., & Merigan, T.C. (1996). Multidrug-resistant HIV1 strains resulting from combination antiretroviral therapies. J. Virol. 70, 1086-1090.
35. 35. Sarafianos, S.G., Pandey, V.N., Kaushik, N. & Modak, M.J. (1995). Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase. Biochemistry 34, 7207-7216.
36. 36. St. Clair, M.H., et al. & Larder, B.A. (1991). Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557-1559.
37. 37. Gu, Z., et al., & Wainberg, M.A. (1994). Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 38, 275-281.
38. 38. Zhang, D., et al., & D' Aquila, R.T. (1994). Resistance to 2′,3′-dideoxycytidine conferred by a mutation in codon 65 of the HIV-1 reverse transcriptase. Antimicrob. Agents Chemother. 38, 282-287.
39. 39. Gu, Z., et al., & Wainberg, M.A. (1995). K65R mutation of human immunodeficiency virus type 1 reverse transcriptase encodes cross-resistance to 9-(2-phosphonylmethoxyethyl)adenine. Antimicrob. Agents. Chemother. 39, 1888-1891.
40. 40. Winters, M.A., et al., & Merigan, T.C. (1998). A 6-basepair insert in the reverse transcriptase of HIV-1 confers resistance to multiple nucleoside inhibitors. J. Clin. Invest. 102, 1769-1775.
41. 41. Larder, B.A. & Stammers, D.K. (1999). Closing in on HIV drug resistance. Nat. Struct. Biol. 6, 103-106.
42. 42. Larder, B.A. & Kemp, S.D. (1989). Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246, 1155-1158.
43. 43. Larder, B.A., Coates, K.E. & Kemp, S.D. (1991). Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J. Virol. 65, 5232-5236.
44. 44. Gao, Q., et al., & Wainberg, M.A. (1993). The same mutation that encodes low-level human immunodeficiency virus type-1 resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37, 1390-1392.
45. 45. Tisdale, M., Kemp, S.D., Parry, N.R. & Larder, B.A. (1993). Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl Acad. Sci. USA 90, 5653-5656.
46. 46. Keulen, W., Back, N.K.T., Van Wijk, A., Boucher, C.A.B. & Berkhout, B. (1997). Initial appearance of the 184lle variant of Lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 71, 3346-3350.
47. 47. Sarafianos, S.G., et al., & Arnold, E. (1998). Structures of Met184→lle and Met184→Val mutants of HIV-1 reverse transcriptase with and without bound nucleic acid reveal template-primer repositioning and steric hindrance mechanism for lamivudine resistance. Antiviral Therapy 3, Supplement 117-18.
48. 48. Schinazi, R.F., et al., & Mellors, J.W. (1993). Characterization of human immunodeficiency virus resistant to oxathiolane-cytosine nucleosides. Antimicrob. Agents Chemother. 37, 875-881.
49. 49. Gosselin, G., et al., & Imbach, J.L. (1994). Anti-human immunodeficiency virus activities of the beta-⌊-enantiomer of 2′,3′-dideoxycytidine and its 5-fluoro derivative in vitro. Antimicrob. Agents Chemother. 38, 1292-1297.
50. 50. Hooker, D.J., et al., & Deacon, N.J. (1996). An in vivo mutation from leucine to tryptophan at position 210 in HIV-1 reverse transcriptase contributes to high-level resistance to AZT. J. Virol. 70, 8010-8018.
51. 51. Lacey, S.F., et al., & Larder, B.A. (1992). Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3′-azido-3′-deoxythymidine. J. Biol. Chem. 267, 15789-15794.
52. 52. Larder, B.A. (1992). AZT resistance suppressed by a mutation conferring HIV-1 resistance to non-nucleoside reverse transcriptase inhibitors. Antimicrob. Agents Chemother. 36, 1171-1174.
53. 53. Kimberlin, D.W., et al., & Whitley, R.J. (1995). Molecular mechanisms of antiviral resistance. Antiviral Res. 26, 369-401.
54. 54. Krebs, R., Immendorfer, U., Thrall, S.H., Wohrl, B.M. & Goody, R.S. (1997). Single-Step kinetics of HIV-1 reverse transcriptase mutants responsible for virus resistance to nucleoside inhibitors zidovudine and 3TC. Biochemistry 36, 10292-10300.
55. 55. Arion, D., Borkow, G., Gu, Z., M., W. & Parniak, M.A. (1998). Phenotypic mechanism of HIV-1 resistance to AZT: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 37, 15908-15917.
56. 56. Canard, B., Sarfati, S.R. & Richardson, C.C. (1998). Enhanced binding of AZT-resistant HIV-1 RT to the AZT-5′-monophosphate-terminated primer. J. Biol. Chem. 273, 14596-14604.
57. 57. Meyer, P.R., Matsuura, S.E., So, A.G. & Scott, W.A. (1998). Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc. Natl Acad. Sci. USA 95, 13471-13476.
58. 58. Kuchta, R.D., Mizrahi, V., Benkovic, P.A., Johnson, K.A. & Benkovic, S.J. (1987). Kinetic mechanism of DNA polymerase I (Klenow). Biochemistry 26, 8410-8417.
59. 59. Majumdar, C., Abbotts, J., Broder, S. & Wilson, S.H. (1988). Studies on the mechanism of human immunodeficiency virus reverse transcriptase: steady-state kinetics, processivity and polynucleotide inhibition. J. Biol. Chem. 263, 15657-15665.
60. 60. Dahlberg, M.E. & Benkovic, S.J. (1991). Kinetic mechanism of DNA polymerase I (Klenow fragment): identification of a second conformational change. Biochemistry 30, 4835-4843.
61. 61. Kati, W.M., Johnson, K.A., Jerva, L.F. & Anderson, K.S. (1992). Mechanism and fidelity of HIV reverse transcriptase. J. Biol. Chem. 267, 25988-25997.
62. 62. Reardon, J.E. (1993). Human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 8743-8751.
63. 63. Hsieh, J., Zinnen, S. & Modrich, P. (1993). Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J. Biol. Chem. 268, 24607-24613.
64. 64. Rittinger, K., Divita, G. & Goody, R. (1995). Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors. Proc. Natl Acad. Sci. USA 92, 8046-8049.
65. 65. Spence, R.A., Kati, W.M., Anderson, K.S. & Johnson, K.A. (1995). Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors. Science 267, 988-993.
66. 66. Johnson, K.A. (1993). Conformational coupling in polymerase fidelity. Annu. Rev. Biochem. 62, 685-713.
67. 67. Moran, S., Ren, X.F.R., Rumney, S.I. & Kool, E.T. (1997). Difluorotoluene, a nonpolar isostere of thymine, codes specifically and efficiently for adenine in DNA replication. J. Am. Chem. Soc. 119, 2056-2057
68. 68. De Jong J.J., et al., & Jurriaans, S. (1999). Insertion of two amino acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 are resistant to multiple nucleoside analogs. AIDS 13, 75-80.